Targeted delivery of etoposide to osteosarcoma cells using poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles

Alp E., Çirak T., Demirbilek M., Mustafa T., GÜVEN E.

Turkish Journal of Biology, cilt.41, sa.5, ss.719-733, 2017 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 41 Sayı: 5
  • Basım Tarihi: 2017
  • Doi Numarası: 10.3906/biy-1612-17
  • Dergi Adı: Turkish Journal of Biology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.719-733
  • Anahtar Kelimeler: Etoposide, Folate targeting, Osteosarcoma, PHBV nanoparticle, Targeted drug delivery
  • Ankara Hacı Bayram Veli Üniversitesi Adresli: Hayır

Özet

Folic acid (FA)-functionalized poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles were prepared to enhance the delivery efficiency of the anticancer drug etoposide for the clinical treatment of osteosarcoma. PHBV nanoparticles were synthesized by emulsification/solvent evaporation technique and obtained in the size range of 200–250 nm and zeta potential range of –21 and –27 mV. Encapsulation efficiency and in vitro drug release were studied. The cytotoxic, apoptotic, and necrotic effects of PHBV nanoparticles were also investigated using Saos-2 osteosarcoma cells. The results obtained in this study demonstrate that etoposideloaded and FA-functionalized PHBV nanoparticles can be successfully used for targeted treatment of osteosarcoma.